Barclays
SKIN icon

Barclays’s SkinHealth Systems SKIN Stock Holding History

Barclays’s Portfolio SKIN Stock Details SKIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.79K Sell
6,910
-14,448
-68% -$11K ﹤0.01% 4781
2026
Q1 		$19K Sell
21,358
-156,929
-88% -$193K ﹤0.01% 4586
2025
Q4 		$248K Buy
178,287
+16,206
+10% +$23.4K ﹤0.01% 4208
2025
Q3 		$323K Sell
162,081
-38,431
-19% -$78K ﹤0.01% 4052
2025
Q2 		$383K Buy
200,512
+119,742
+148% +$169K ﹤0.01% 3909
2025
Q1 		$108K Sell
80,770
-37,150
-32% -$56.6K ﹤0.01% 4375
2024
Q4 		$187K Buy
117,920
+11,817
+11% +$18.6K ﹤0.01% 4346
2024
Q3 		$153K Buy
106,103
+73,425
+225% +$120K ﹤0.01% 4430
2024
Q2 		$62.7K Sell
32,678
-93,456
-74% -$263K ﹤0.01% 4118
2024
Q1 		$560K Sell
126,134
-13,373
-10% -$43.4K ﹤0.01% 3520
2023
Q4 		$434K Buy
139,507
+45,220
+48% +$170K ﹤0.01% 3973
2023
Q3 		$568K Sell
94,287
-50,948
-35% -$358K ﹤0.01% 2714
2023
Q2 		$1.22M Sell
145,235
-54,498
-27% -$566K ﹤0.01% 2182
2023
Q1 		$2.52M Buy
199,733
+50,064
+33% +$579K ﹤0.01% 2022
2022
Q4 		$1.36M Sell
149,669
-206,158
-58% -$2.23M ﹤0.01% 2554
2022
Q3 		$4.2M Buy
355,827
+160,327
+82% +$2.03M ﹤0.01% 1274
2022
Q2 		$2.51M Sell
195,500
-606,914
-76% -$8.13M ﹤0.01% 1692
2022
Q1 		$13.5M Buy
+802,414
New +$13.2M 0.01% 814

Other funds holding SKIN

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays's SKIN Position: Q2 2026 in Review

Barclays reduced its SkinHealth Systems (SKIN) stake by 68% in Q2 2026, selling an estimated $11K and leaving 6,910 shares worth $4.79K. The position accounts for ﹤0.01% of the portfolio, ranked #4781.

Barclays first reported a position in SKIN in Q1 2022 and has held it in 18 quarters since. The position peaked at $13.5M in Q1 2022. 96 funds tracked by Wall St. Rank hold SKIN as of Q2 2026.

  • Barclays held 6,910 shares of SkinHealth Systems worth $4.79K as of Q2 2026.
  • Barclays sold 14,448 SkinHealth Systems shares in Q2 2026, an estimated $11K.
  • SkinHealth Systems made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4781 holding.
  • Barclays first reported a position in SkinHealth Systems in Q1 2022 and has held it in 18 quarters since.
  • Barclays's SkinHealth Systems position peaked at $13.5M in Q1 2022.
  • 96 funds tracked by Wall St. Rank held SkinHealth Systems as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.